North American rights to formulate AMRIX. The drug is used as an adjunct to rest and physical therapy for relief of muscle spasm associated with acute musculoskeletal conditions.
Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
---|
This information is available in the PitchBook Platform. To explore ECR Pharmaceuticals (Amrix Product Line)‘s full profile, request access.
Request a free trialInvestor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|
This information is available in the PitchBook Platform. To explore ECR Pharmaceuticals (Amrix Product Line)‘s full profile, request access.
Request a free trial